<p>NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will present updated Phase 1/2 data for vep
EUR/USD may continue to give back the advance from the April low (1.0727) as the ECB retains a dovish forward guidance following the German Constitutional Court ruling.
Leave a Comment